Latest News
Shorter, more intensive treatment for TB meningitis in children is not as effective as the standard treatment
SURE trial results presented today at the Union conference did not show that a shorter, intensive treatment for TB meningitis in children is as good as the standard treatment. Adding aspirin also showed no benefit.
New methodology guidance on inverse probability of censoring weighting in clinical trials
Our methodologists published guidance on how to apply IPCW effectively and how to stabilise IPCW weights to improve precision, without overlooking potential bias.
Our tuberculosis research at The Union World Conference on Lung Health 2025
Our researchers and collaborators will present the latest results of our TB clinical trials, including new findings from the SURE trial.
A combination of two immunotherapy drugs benefits people with kidney cancer
Results from the RAMPART trial show that giving durvalumab and tremelimumab after surgery helps prevent kidney cancer coming back.
Weekly chemotherapy with bevacizumab improves ovarian cancer survival compared to having it once every three weeks
New results from the ICON8B trial were presented at the ESMO 2025 Conference.